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Abstract 
Aim:  To examine the factors that lead to attrition and success in a weight management program 
for patients diagnosed with type 2 diabetes.  The current study specifically examines the effect of 
quality of life, expected weight loss, self-esteem, and early weight loss on attrition and success 
rates. 
Methods:  Archival data from a study conducted at the University of Pennsylvania Center for 
Weight and Eating Disorders were used.  Seventy-nine overweight and obese subjects with type 
2 diabetes participated in a lifestyle modification program over 40 weeks.  Logistic regression 
analyses were performed to explore the relationship between early weight loss, expected weight 
loss, self-esteem, and quality of life on attrition and success rates in this population.  
Results: Subjects who lost the greatest amount of weight at week five, were significantly more 
likely to achieve a 5% weight reduction at week 40 and were also significantly less likely to drop 
out of the program before 40 weeks.  No significant relationship was found between self-esteem, 
expected weight loss, and quality of life in this population. 
Conclusion: Overweight and obese subjects with type 2 diabetes who show early success in a 
weight management programs are more likely to stay in the program longer and achieve a 
significant reduction in weight.  Professionals working with this population should encourage 
early weight loss success (as opposed to concentrating only on long term reductions) as well as 
provide additional support to patients who are struggling early in the program in order to reduce 
attrition rates and to increase the likelihood of success.  
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 Chapter One 
Statement of the Problem 
 
Obesity is a major problem in the US and around the world.  It is estimated that over 30% 
of the US adult population is obese (Ogden et al., 2006).  Obesity is associated with many co-
morbid medical conditions such as cardiovascular diseases, high blood pressure, high 
cholesterol, knee and joint pain, and type 2 diabetes (Kopelman, 2007).  Many of these health 
problems can be prevented through a reduction in weight (Anderson, Kendall, & Jenkins, 2003). 
Diseases such as type 2 diabetes require a great deal of attention.  In order to maintain 
blood glucose in a healthy range, people with type 2 diabetes must limit their intake of 
carbohydrate, in general, and sugar, in particular.  In some cases, patients may need to balance 
their carbohydrate and sugar intake with oral or injectable medications such as insulin.  One of 
the largest contributing factors to the development of type 2 diabetes is being overweight and 
being obese.  It is estimated that 60 – 90% of the variance in the development of type 2 diabetes 
in the population can be attributed to obesity (Anderson, Kendall, & Jenkins, 2003).  A 5-10% 
reduction in weight can decrease the risk of developing diabetes and dramatically increase 
glycemic control in patients already diagnosed with type 2 diabetes (Blackburn, 1995; Klein et 
al., 2004; Nathan, 2002).   
Despite extensive knowledge on weight reduction techniques, weight loss programs 
continue to suffer from high attrition rates and limited success (Fabricatore et al., 2009; 
Volkmar, Stunkard, Woolston, & Bailey, 1981).  Unfortunately, the factors predicting attrition or 
success continue to elude researchers.  Knowing the factors that lead to success and to attrition 
can not only assist program developers in identifying patients who may struggle with their 
weight loss, but also aid them in helping to remedy issues that contribute to attrition before or 
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during the weight loss program.  By determining the factors that contribute to weight loss 
success and to attrition, treatment providers can alter their programs to increase the rate of 
success and aid participants in losing more weight.  In patients with type 2 diabetes, this may be 
the key to balancing their blood glucose, leading to a remediation in symptoms and increased 
control over their illness without the use of costly medications. 
Purpose of the Study 
 
The purpose of this study is to examine the factors that lead to attrition or lead to success 
in a weight reduction program with patients diagnosed with type 2 diabetes.  The current study 
will specifically examine the effect of quality of life, expected weight loss, self-esteem, and early 
weight loss on attrition and success rates.  The data in this study will be extracted from a larger 
study measuring the effects of a low-glycemic load diet (LGL) versus a low fat diet (LF) for 
weight loss in a type 2 diabetic population.   
Relevance to Goals in the Program 
 
Treatment of overweight and obesity is not only medical, but also psychological.  People 
attempting to lose weight will experience greater difficulty if they are not motivated toward 
weight loss or feel that they are unable to be successful in following their weight loss plan.  
Patients with type 2 diabetes who are attempting to reduce their weight will have the additional 
burden of adjusting their food intake to control their blood glucose.  They may also contend with 
using insulin medications, which may stimulate hunger, increasing the difficulty of staying on a 
controlled diet.   
Research has shown that the longer people are able to follow a specific weight reduction 
plan, the more success they will have (Perri, Nezu, Patti, & McCann, 1989).  Psychologists 
working with this population consistently search for ways to motivate clients and to keep them 
ATTRITION AND SUCCESS IN WEIGHT  3 
engaged in the weight reduction process.  By identifying factors that lead to success and to 
attrition, weight loss programs and mental health workers can specifically target these factors in 
order to decrease attrition rates.  By accurately identifying issues, the treatment provider can 
build in safeguards to help reduce the rate of attrition and increase the chance of successful 
outcomes.  This may include working with the patient on issues surrounding motivation, 
depression, or even added structure and support that will increase their chance of success in 
losing weight. 
ATTRITION AND SUCCESS IN WEIGHT  4 
Chapter Two: Literature Review 
Obesity 
 
Obesity is defined for adults by using a ratio between weight and height commonly 
known as the body mass index (BMI).  For the majority of people, BMI will positively correlate 
with the amount of fat stored in the body (Centers For Disease Control And Prevention, 2009).  
BMI, therefore, can be considered an alternative measure of body fat instead of using techniques 
such as dual energy x-ray absorptiometry (DXA), skin fold thickness measurements, 
bioelectrical impedance, isotope dilution, or underwater weighing.  BMI is calculated by 
dividing weight by squared height (kg/m
2
).  A person is considered overweight when his or her 
BMI is measured at 25 kg/m
2
 or higher and is considered obese when his or her BMI reaches 30 
kg/m
2
 and above (Centers For Disease Control And Prevention, 2009).  
Obesity is a major epidemic in the United States (U.S.) and also around the world.  The 
most recent statistics state that over 32.2% of men and 35.5% of women in the U.S. are obese 
(Ogden et al. 2006). Obesity carries with it many risks and problems.  Some of the most common 
co-morbid health issues with obesity are high blood pressure, high cholesterol, knee and joint 
problems, various cardiovascular diseases, and type 2 diabetes (Kopelman, 2007). 
Emotional Effects of Obesity 
 
Obesity affects mental, as well as physical health.  Although some research has 
demonstrated the idea that obese individuals in the general population display normal 
psychological functioning, others argue that there is a higher rate of psychological disorders in 
the obese population.  Obesity in itself can serve as a risk factor for later development of 
depression and related complications (McElroy et al., 2004).  This increased risk for the 
development of depression or other psychological problems increases positively with BMI.  A 
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study by Schowlter et al. (2008) showed significant decreases in Beck Depression Inventory 
scores as BMI decreased following gastric banding surgery.  Younger women with severe 
obesity (BMI >40) and poorer body image appear to be at the greatest risk for developing 
depression (Dixon, Dixon, & O'Brien, 2003).  This may be due to the increase in health problems 
and discrimination that occurs with a higher BMI, or due to more internal dissatisfaction because 
of body image (Fabricatore & Wadden, 2003).  
Symptoms of depression in the obese population may increase the risk for further weight 
gain and for difficulty in losing weight.  Murphy et al. (2009) researched how depression 
differed among obese and non-obese subjects.  Findings from this study showed a five-fold 
increase in overeating during periods of depression in the obese population.  This increase in 
eating behavior made dieting more difficult and has led to a vicious cycle of weight gain and 
depression. It is estimated that 20-30% of individuals seeking weight reduction suffer from binge 
eating or depression (Wadden & Phelan, 2002).   
The search for a genetic link between depression and obesity has resulted in many 
contradictory findings.  This is in part due to the many mediating and moderating factors of both 
depression and of obesity.  These factors include environmental influences (socioeconomic 
status, teasing, stress, and food quality), psychological factors such as trauma, or genetic factors 
such as gender, gene-environment interactions, or even chromosomal differences (Stunkard, 
Faith, & Allison, 2003).  It is hypothesized that although many obese subjects may not meet 
criteria for a psychological diagnosis, there may be a higher sub clinical level of problems in this 
population.  This includes increases in sub clinical depression, binge eating behavior, anxiety, 
and stress.  These differences may be detected by examining the obese patients’ overall quality 
of life (Fabricatore & Wadden, 2003). 
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To explore the early connections between obesity and depression, one meta-analysis 
examined the effect that obesity had on self-esteem and on depression levels on children.  
Although many studies produced conflicting findings, the overall conclusion was that obesity, 
depression, and self-esteem were not positively correlated in a community sample.  This 
suggested that obesity is not generally related to depression and to low self-esteem in children.  
 The analysis did find a higher sub clinical level of depression and of problems with self-
esteem in the community sample of overweight and obese children, and found a high correlation 
of depression and self-esteem issues, but only in the treatment-seeking population.  It is difficult 
to determine whether or not this population was more highly aware of their issues and decided to 
seek treatment, if they had other co-morbid, unrelated issues along with their weight problems, 
or if the treatment itself caused this population to feel more depressed and thus decrease self-
esteem (e.g., depressed over having to enter treatment because of their weight).  As expected, all 
these results fluctuated due to gender and cultural factors. Caucasian females were more 
seriously affected, but males and African American and Hispanic children reported less 
depression or fewer problems with self-esteem because of their weight (Wardle & Cooke, 2005). 
Obesity and Quality of Life 
 
Obesity is seen to affect a person’s quality of life dramatically and negatively.  Quality of 
life has been defined as not just an absence of disease, but also as the presence of physical, 
mental, and social well being (Testa & Simonson, 1996).  Changes in quality of life are seen in 
various measurable areas such as vitality, bodily pain, social functioning, role functioning, 
emotional functioning, and mental health (Ross et al., 2009).  Obesity can negatively affect every 
area of life quality from physical functioning, pain, and especially psychological status. 
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Health-Related Quality of Life (HRQOL) is a measurement of how a person’s health 
affects his or her overall physical and mental functioning.  Measurements specifically target 
limitations in social, occupational, and physical functioning and may be tailored to assess quality 
of life in patients experiencing different physical conditions.  Many instruments have been 
developed to measure this concept; some of the most reliable instruments are the Short Form-36 
(SF-36) (Ware, Snow, Kosinski, & Gandek, 1993) and the Impact of Weight on Quality of Life 
(IWQoL).  The SF-36 was designed to measure general health related quality of life and the 
IWQoL measures more specific weight related quality of life issues including weight’s impact on 
physical functioning, self-esteem, sexual life, public distress, and work (Kolotkin, Crosby, 
Kosloski, & Williams, 2001; Wadden & Phelan, 2002).  The Impact of Weight on Quality of 
Life - Lite (IWQOL-Lite) was later developed as a brief assessment of quality of life in the obese 
population and has been demonstrated to be a valid and reliable measure with this population 
(Kolotkin & Crosby, 2002). 
Obesity has been shown to have a negative affect on obese individuals’ health-related 
quality of life, as well as having negative effects on their social interactions and job satisfaction.  
Individuals with a high BMI were more likely to have poor physical functioning including 
disruption in basic life activities such as walking, bending, kneeling, and stooping (Han, Tijhuis, 
Lean, & Seidell, 1998).  Research done with obese children has shown health related quality of 
life scores similar to those of children with cancer (Schwimmer, Burwinkle, & Varni, 2003).  
Obese children have also faced increased levels of teasing, discrimination, stigma, and have been 
characterized more negatively than average-weight peers (Cramer & Steinwert, 1998).  These 
early negative interactions can lead to later negative self-evaluations and lower perceived quality 
of life in social and vocational areas.  Early levels of stigmatization and discrimination may carry 
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over into later assessment of body image and self-efficacy.  When measuring adults’ quality of 
life, one can see the same negative evaluations of bodily pain, general health perception, and 
vitality in adults seeking treatment for obesity (Fontaine, Bartlett, & Barofsky, 1998). 
Although many factors may come into play when assessing quality of life in the adult 
obese population (e.g., socioeconomic status [SES] and general health), there is an overall 
improvement in reported HRQOL symptoms as weight decreases (Nickel, Loew, & Bachler, 
2007).  Along with the positive effects in quality of life, Nickel et al. also saw a reduction in 
depression and anxiety with weight loss.  It is important to note that although there is a 
significant overlap in measures of anxiety, depression, and quality of life, the measures used in 
this study (Hospital Anxiety and Depression Scale [HADS-D] and the SF-36) were shown to be 
acceptable instruments when examining anxiety, depression, and quality of life (Fossa & Dahl, 
2002).  
Vocational and Financial Implications of Obesity 
 
Vocational success is an important component of quality of life. Overweight workers 
were 12 times more likely than normal weight workers to report discrimination in the work force 
and severely obese employees were more than 100 times more likely to report discrimination 
(Roehling, Roehling, & Pichler, 2007).  The obese population faces overall lower rates of 
employment than the general population.  Whether or not this is due to health complications 
(which may interfere with productivity in the workforce) or is due to job hiring discrimination, 
the result is that obesity will negatively impact a person’s ability to make a living (Morris, 2007).  
This perceived discrimination often leads to attempts to conceal weight through dress or in 
avoiding work functions, and in lower levels of self-confidence than that which is seen in non-
obese subjects (Puhl & Heuer, 2009).  Bias in the work force can be costly for the individual, to 
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the company, and to society at large because of decreased productivity, increased medical 
expenses paid by company sponsored health plans, and increased use of sick time, including paid 
and unpaid days off for recovery (Rothblum, Brand, Miller, & Oetjen, 1990). 
The financial costs of obesity are astounding and continue to grow yearly.  Current 
estimates are difficult to tabulate due to the overlap of obesity with other diseases including 
chronic diseases such as type 2 diabetes, cardiovascular disease, several types of cancer, 
musculoskeletal disorders, sleep apnea, and gallbladder disease (Finkelstein, Fiebelkorn, & 
Wang, 2003).  Tsai, Williamson, and Glick (2010) estimated that individuals with a BMI ≥ 30 
kg/m
2
 pay approximately $1723 more annually in additional medical expenses; Finkelstein, 
Trogdon, Cohen, and Dietz (2009) currently estimate that obese patients cost the healthcare 
system 42% more in healthcare costs, with Medicare, Medicaid, and private insurers picking up 
the greater cost of the bill.   
Unfortunately, the cost of obesity does not end with healthcare.  Social costs include 
absence from work and reduced productivity in corporations, unemployment (which reduces tax 
revenue and increases government expenditure), and even extraneous business expenses such as 
the costs of larger seats in theaters and fuel for aircraft.  These costs are more difficult to 
measure but can have major deleterious effects on society (McCormick, 2007).  
Etiology of Obesity 
 
Biological 
 
Extensive research into the genetic contribution to obesity has been conducted over the 
years.  Twin studies conducted by Sorensen, Price, Stunkard, and Schulsinger (1989) 
demonstrated that environment alone was not a strong predictor of weight and that genetics had a 
strong influence on who would become obese.  Unfortunately, the mechanisms of fuel 
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homeostasis are not well understood (Marti, Moreno-Aliaga, Hebebrand, & Martinez, 2004).  It 
is generally believed that the regulation of weight is controlled by three interrelated components.  
These components are food intake, nutrient turnover and thermogenesis, and body fat stores.  
Researchers believe that the balance of these three interrelated, yet self-controlled components 
lead to changes in weight (Martinez, 2000). 
When consuming foods, the body releases chemicals which control the appetite and 
satiety hormones.  This process allows the person to adjust quantitative as well as qualitative 
nutrient intake.  Heavily influenced by genetic research, scientists now believe that human food 
intake is not as voluntary as once thought and may instead be primarily driven by genetics 
(Barsh, Farooqi, & O'Rahilly, 2000).  The second process of nutrient turnover and thermogenesis 
affects the way foods are broken down and turned into energy.  When the intake of any meal is 
not balanced between fats, proteins, and carbohydrates, this process may slow down, causing 
more food to be deposited as fat instead of burned as fuel (Johnston, Day, & Swan, 2002).  When 
a person stores food instead of burning it, that person will experience an increase in weight and 
consequently an increase in hunger (Martinez, 2000). 
Finally, the body’s natural maintenance of body fat stores signals the brain on how many 
of the calories taken in should be stored.  Genetically, human beings are programmed for 
survival.  This means that the body will signal the brain when it senses that a person is going 
below a certain amount of energy (fat) storage (Speakman, 2007).  Obesity itself may alter the 
way the body responds to internal satiety and hunger signals.  When the body’s homeostatic “set 
point” is thrown off by obesity, this system may trigger the body to believe that it needs more fat 
than it actually needs, leading to an increase in body fat storage and increased weight (Barsh, 
Farooqi, & O'Rahilly, 2000; Martinez, 2000). 
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Although current studies estimate the genetic heritability of obesity to be between 45-
75%, that is only part of the picture (Farooqi & O'Rahilly, 2007).  Genetic variants that were 
previously silent may now be triggered by the availability of high-energy high-fat foods, coupled 
with a sedentary lifestyle (Martinez, 2000).  These environmental influences may interact with 
genetic vulnerabilities to alter a person’s weight.  Unfortunately, it is difficult to separate the 
genetic from the environmental influence and pinpoint how each will affect the other (Marti, 
Moreno-Aliaga, Hebebrand, & Martinez, 2004).  Human genetics protects a person from 
nutritional deficiencies in energy-poor environments.  It is hypothesized that the modern 
“obesogenic” environment has overwhelmed the body’s ability to balance energy expenditure, 
which leads to an over abundance of calories and an increase in obesity (Bellisari, 2008). 
Environmental 
 
The probability is low that the human gene pool has changed so dramatically in the last 
century that this change accounts for a significant increase in obesity.  Scientists are looking at 
other factors that may have led to such a dramatic change in the human body (Poston & Foreyt, 
1999).  The “obesogenic environment” was a term coined to describe environments that 
encourage high calorie and high fat food consumption and discourage physical activity 
(Swinburn, Egger, & Raza, 1999).  These areas essentially encourage obesity by changing the 
energy balance of the inhabitants of these environments (Reidpath, Burns, Garrard, Mahoney, & 
Townsend, 2002).  There is a growing concern over the rates of obesity in industrialized 
countries and specifically in low SES areas.  The prevalence of obesity in these areas has been 
traced to stress and psychological effects, culture, and the availability of high calorie, low-
nutrient fast foods.  The relationship between low SES and obesity appears to transcend 
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racial/ethnic and cultural differences.  These effects appear early and last through the low SES 
individual’s lifetime (Everson, Maty, Lynch, & Kaplan, 2002). 
Some believe that this relationship between SES and obesity may be related to the 
availability of high fat, low nutritive, inexpensive fast foods.  Analysis of the lowest SES 
environments reveals that this population is exposed to 2.5 times more fast food restaurants than 
those living in the richest areas (Reidpath et al., 2002).  The increase in fast food consumption 
has been linked to an increase in overall calories consumed.  One study by Dumanovsky, Nonas, 
Huang, Silver, and Bassett (2009) examined the average caloric content of food purchased 
during lunch in many popular fast food chains in New York.  Their results showed that the 
average fast food meal was around 827 calories and that one in three customers purchased meals 
>1000 calories.  These high calorie lunches greatly exceeded the 750-calorie fast food meal 
recommended by the restaurant industry’s “healthy dining finder” (National Restaurant 
Association, 2010).  
Behavioral 
 
Behavioral contributions to obesity tend to be clearer for researchers looking for a cure to 
the obesity epidemic.  Living in an obesogenic environment contributes to the lack of or 
discouragement of physical activity, to ease of obtaining energy dense and processed foods that 
are high in fat and salt, and to the development of poor eating behaviors. 
Passive behaviors such as television watching and video game playing have steadily 
increased (Robinson, 1998).  These sedentary activities have been linked with a decrease in 
energy output and an increase in weight.  Children viewing increased amounts of television are 
also bombarded with more ads for calorie dense foods and sugary snacks.  This advertising can 
influence their food choices, leading to an increased consumption of high calorie foods and 
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weight gain.  It has been shown that children will increase their intake of calorie dense snacks 
and decrease their intake of healthy snacks during periods of inactivity (Rennie, Johnson, & 
Jebb, 2005).   
Treatment of Obesity 
 
Calorie Restriction/Dieting 
 
The American Dietetic Association (ADA) recommends a balance of calories, proper 
nutrition, and exercise as a way to lose weight and maintain health (American Dietetic 
Association, 2010).  The ADA weight loss data suggests a 500-1000 calorie a day deficit in order 
to safely lose ~ 1 lb a week. This balance of “calories in” versus “calories out” is often difficult 
to achieve in today’s fast paced environment, but has been shown to be effective for people able 
to follow this lifestyle intervention. 
Americans spend over 33 billion dollars a year on dieting programs and products.  Most 
programs rely on a system of energy imbalance resulting in a deficit of calories leading to weight 
reduction.  These weight loss strategies may rely on decreasing the intake of specific nutrients 
(e.g., fat or carbohydrate), increasing exercise, eating low-calorie meal replacements, taking diet 
pills (either to increase satiety or decrease hunger), or fasting (Kruger, Galuska, Serdula, & 
Jones, 2004).  These weight reduction programs have found an average result of 8%-10% weight 
reduction in 16-26 weeks of treatment when following a standard lifestyle modification program.   
Exercise Programs 
 
Exercise programs for weight loss have become increasingly popular.  In the year 2000, it 
was estimated that 32.8 million Americans spent 11.6 billion dollars on gym memberships 
(Dellavigna & Malmendier, 2006).  Using exercise as a means for weight loss has shown limited 
results, as compared with many weight loss programs choosing to focus primarily on calories 
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consumed instead of calories burned (Donnelly & Smith, 2005).  Although exercise programs 
have been shown to have a positive effect on food choice and eating behaviors of the dieter 
(Elder & Roberts, 2007), it is generally recommended that controlling calorie consumption is a 
better way to manage or lose weight.  This increase in healthy food choices may be an additional 
benefit to recommending a healthy active lifestyle to the average weight loss patient.  Exercise 
does present the dieter with some additional benefits beyond weight reduction.  It can often 
decrease insulin resistance and improve cardiovascular health.  Unfortunately, its overall role in 
weight reduction is limited (Ross et al., 2000). 
Behavioral Treatment of Obesity 
 
Behavior therapy is a treatment based on the principles of classical and operant 
conditioning.  According to this theory, eating behavior is prompted by antecedent events that 
become strongly linked over time.  In this treatment, patients are taught how to identify those 
cues and learn new responses (Foster, 2006) while operant conditioning rewards health-
promoting behaviors and extinguishes health-inhibiting behaviors.  Behavior therapy is goal-
directed, process oriented, advocating small rather than large changes (Foster, Makris, & Bailer, 
2005).  Behavioral treatment for obesity involves multiple components such as keeping a food 
diary, activity records, slower eating, nutritional education, and identification of eating cues.  
Behavior therapy can also increase positive behaviors through reward, causing the patient not 
only to eliminate some of the negative behaviors, but also slowly to adopt more positive 
responses (Foster, 2006). 
Behavior therapy is sometimes coupled with cognitive skills such as problem solving and 
cognitive restructuring (Foster, Makris, & Bailer, 2005).  The underlying theory in cognitive 
therapy is that thoughts directly affect feelings and behaviors.  Teaching problem solving and 
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cognitive restructuring skills to patients may help prevent relapse when they are unable to meet 
certain weight loss goals or begin having difficulty following their healthy eating plan.  These 
cognitive techniques can help patients set realistic goals for weight and behavior change, correct 
negative thoughts that may occur during the dieting process, and evaluate their own success in 
modifying their eating and exercise habits (Foster, 2006).  
Cognitive behavior therapy and behavior therapy can provide many helpful techniques to 
the patient attempting to lose weight (Fabricatore, 2007).  Behavior therapy provides techniques 
such as self-monitoring, goal setting, and stimulus control.  These techniques help the patient 
modify his or her food environment in order to decrease access to additional calories.  Cognitive 
behavior therapy techniques such as problem-solving and cognitive restructuring can be helpful 
in altering a patient’s negative thoughts about food and identify events that may lead to 
overeating (Fabricatore).   
Lifestyle Modification 
 
When cognitive and behavioral interventions are packaged together with exercise and 
diet recommendations, these treatments typically result in weight losses of around 5-10% of 
initial weight, which has been shown to produce significant improvements in obesity related 
illness such as problems with blood pressure and cholesterol (Blackburn, 1995).  This “Lifestyle 
Modification” approach has been used to treat both overweight individuals and obese individuals 
(Wadden, Butryn, & Byrne, 2004), as well as type 2 diabetes (Delahanty & Nathan, 2008). 
Bariatric Surgery 
 
In cases of severe obesity, a surgical option may be necessary to reduce weight.  Two 
main procedures used in this population are adjustable laparoscopic gastric banding surgery and 
Roux-en-Y gastric bypass surgery.  In each procedure, caloric intake is reduced by decreasing 
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the volume of food that can be consumed at any given time.  Both of these procedures induce 
large weight losses and may help to alleviate medical co-morbidities and reduce mortality in the 
patient (Blackburn, Hu, & Hutter, 2009; Garb, Welch, Zagaris, Kuhn, & Romanelli, 2009).  
Patients are eligible for this surgery if they have a BMI of at least 40 kg/m
2
, or a BMI of 35 to 
39.9 kg/m
2
 and also exhibit obesity-related medical co-morbidities such as type 2 diabetes, sleep 
apnea, respiratory problems, osteoarthritis, gallbladder disease, or hypertension (Hope, 
Kumanyika, Whitt, & Shults, 2005).  Although each procedure presents its own set of risks such 
as surgical complications and pain, the long-term effect of bariatric surgery reduces mortality in 
extremely obese patients and may improve overall quality of life (Nickel et al., 2007). 
Diabetes 
 
 The World Health Organization (WHO) defines diabetes as “a metabolic disorder of 
multiple etiologies characterized by chronic hyperglycemia with disturbances of carbohydrate, 
fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both” 
(World Health Organization, 1999). This hyperglycemia, or abnormally high concentration of 
glucose in the blood, is a significant risk factor of microvascular and macrovascular disease. 
 A key component to diabetes is the deficiency of, or inability to use insulin in the body.  
This insulin insensitivity disrupts the absorption of glucose in the muscles, leading to a build up 
of glucose in the blood.  After glucose begins to build in the blood, the result is the destruction of 
certain microvascular systems, which can lead to both short and long term damage to the body 
(American Dietetic Association, 2010). 
 Some of the physical effects of diabetes on the body are ketoacidosis (buildup of ketone 
bodies typically used for energy, which can be fatal in extreme cases), ischemic heart disease 
(reduced blood supply to the heart muscle), stroke, retinopathy (damage to the retina leading to 
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possible blindness), peripheral vascular disease (obstruction of the large arteries in the legs and 
arms), renal failure (kidney failure or breakdown), neuropathy (damage to the nerves of the 
peripheral nervous system), charcot joints (progressive deterioration of a weight bearing joint), 
and autonomic dysfunction (American Dietetic Association, 2010).   
 Most common symptoms of diabetes are polydipsia (thirst), blurred vision, weight loss, 
and polyuria (passage of large volumes of urine).  Many diabetic patients will not experience the 
symptoms of their disease for years and may experience organ dysfunction before being 
diagnosed with diabetes by a physician (American Dietetic Association, 2010).     
Prevalence of Type 2 Diabetes  
 
 Type 2 diabetes is the most common form of diabetes.  Although specific causes of type 
2 diabetes are unknown, risk of developing type 2 diabetes will increase with increased age, 
weight, and with decreased physical activity.  It is estimated that 23.6 million Americans (7.8% 
of the U.S. population) have diabetes.  An additional 5.7 million people are believed to have 
diabetes but are undiagnosed and unaware.  In the U.S., diabetes currently affects 14.9 million 
(9.8%) non-Hispanic whites aged 20 years or older and 3.7 million (14.7%) non-Hispanic blacks 
aged 20 years or older.  Type 2 diabetes affects 186,300 people aged 20 and younger, 
representing 0.2% of all people in this age group (Centers for Disease Control and Prevention, 
2008).  Worldwide estimates predict that diabetes prevalence will continue to grow and even 
double between 2000 and 2030.  This doubling of diabetes rates is due to industrialization of 
developing countries and to more people surviving into old age (> 65).  The largest increase in 
diabetes is expected to occur in India and China where both industrialization and life expectancy 
are increasing dramatically (Wild, Roglic, Green, Sicree, & King, 2004). 
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Mortality Rates 
 
 Despite the tendency for diabetes to be underreported as a cause of death, it was listed as 
the seventh leading cause of death on all U.S. death certificates in 2006.  It is reported that the 
risk of death is twice as high for people with diabetes as it is for people without diabetes of 
similar age (American Dietetic Association, 2010). 
Physical Effects of Diabetes 
 
 Diabetes may result in many health problems including heart disease, high blood 
pressure, blindness, kidney disease, nervous system damage, and dental disease.  Heart disease 
was listed on approximately 68% of diabetes related death certificates among people 65 years or 
older in 2004.  Strokes were noted on 16% of diabetes related death certificates and heart disease 
and stroke death rates were about 2 to 4 times higher in diabetics than that of adults without 
diabetes (National Institute of Health, 2007).  In 2003-2004, 75% of self reported diabetics had 
high blood pressure or were using prescription medications for hypertension.  Diabetes is 
reported to be the leading cause of new cases of blindness among adults age 20-74; diabetic 
retinopathy causes 12,000 to 24,000 new cases of blindness each year.  Diabetes is the leading 
cause of kidney failure in the U.S., accounting for 44% of all new cases (National Institutes of 
Health, 2007). 
 About 60% to 70% of people with diabetes have mild to severe forms of nervous system 
damage.  This may include impaired sensation in feet or hands, slowed digestion of food in the 
stomach, carpal tunnel syndrome, erectile dysfunction, or other nerve problems.  Severe nerve 
disease is a major contributing factor to lower extremity amputations, with more than 60% of all 
nontraumatic lower-limb amputations occurring in people with diabetes.  People with type 2 
diabetes are twice as likely as those without diabetes to suffer from periodontal gum disease.  
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People with poorly controlled diabetes were more than three times more likely to suffer from 
severe periodontitis than those without diabetes because of the decrease in circulation and the 
body’s impaired ability to heal (National Institutes of Health, 2007). 
Costs of Diabetes 
 
 It is estimated that patients with diabetes spent 2.3 times more in direct medical costs 
than individuals without diabetes.  Total direct and indirect costs of diabetes care in the U.S. was 
said to total 174 billion dollars (Centers for Disease Control and Prevention, 2008).  Dissecting 
the direct cost of diabetes treatment from obesity and other co-morbid disorders has proven 
difficult for researchers.  Actual medical treatment of diabetes, through the development of oral 
medications and technical advances, has become cheaper and has led to more accurate glucose 
monitoring. However, patients are developing diabetes at a younger age, putting them at risk for 
the development of more co-morbid disorders later in life.  This early development of diabetes, 
coupled with the increased risk of co-morbid disease has put a strain on the healthcare system.  
Although these are not easily identified in treatment cost surveys, diabetes itself has proven to be 
a costly disease both for the patient and for society at large (Roehrig, Miller, Lake, & Bryant, 
2009). 
Treatment of Type 2 Diabetes 
 
 Type 2 diabetes treatment is a complex process of balancing glucose and insulin.  Many 
patients with type 2 diabetes can successfully balance their symptoms with proper diet and 
exercise.  This may be a glucose-controlled diet relying on limiting carbohydrates and sugars to 
reduce the body’s need for insulin, or just counting carbohydrates and monitoring blood sugar in 
order to keep sugars from exceeding a healthy level. 
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 Many patients with type 2 diabetes require oral medications to control their glucose and 
insulin.  These medications may act to increase insulin sensitivity, or increase insulin production. 
More severe cases of type 2 diabetes may require the direct injection of insulin.  This most often 
occurs when the patient’s pancreas ceases to produce insulin or the body is unable to detect the 
insulin being produced. 
Relationship between Diabetes and Obesity 
 
 There is a strong relationship between type 2 diabetes and obesity.  Zimmet, Alberti, and 
Shaw (2001) coined the phrase “diabesity”, relating to the interdependence of each diagnosis and 
examined the progression from obesity to diabetes in people who have a genetic predisposition to 
diabetes and became obese, as well as those who have the same history but did not become 
obese. The results of this study showed glucose impairment in both populations, but a much 
higher rate of type 2 diabetes in the group that later became obese.  The reverse effect was also 
seen when previously obese subjects were able to lose ~10kg of weight resulting in better insulin 
secretion and less insulin resistance.    
The development from being overweight to developing type 2 diabetes appears to be a 
stepwise process.  It begins with a progressive defect in insulin secretion, with the slow 
development of insulin resistance.  As body fat increases, the body begins to resist insulin.  The 
pancreas responds by secreting more insulin into the bloodstream to produce normoglycaemia.  
Over time, the body’s ability to produce insulin decreases and the result is the development of 
type 2 diabetes (Golay & Ybarra, 2005). 
Unfortunately, the number of people becoming obese continues to climb.  The largest 
growing group are people with class III obesity (people with a BMI >40).  This rise in weight 
occurs in both the type 2 diabetic population as well as in people without diabetes.  Men 
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diagnosed with both type 2 diabetes and obesity are 40% more likely to have a cardiovascular 
problem and women diagnosed with type 2 diabetes have increased their risk by 300% (Kramer 
et al. 2009).  As the result, this combination of diabetes and obesity greatly increases mortality.   
Weight Loss Programs and Diabetes 
 
Because of the strong relationship between weight and type 2 diabetes, many programs 
have attempted to gear their treatment towards diabetes prevention and treatment by reducing 
weight and macronutrient contributions to the development of the disease (Klein et al., 2004).  
Dieting programs have explored the relationship between type 2 diabetes and fat consumption 
(Riserus, Willett, & Hu, 2009) as well as carbohydrate amount and type (Sheard et al., 2004).  
Many studies have examined the relationship between dietary fats, proteins, and carbohydrates 
and their benefits in weight reduction as well as their effect on insulin secretion in obese and 
overweight subjects (McAuley et al., 2005; Samaha et al., 2003; Yancy, Olsen, Guyton, Bakst, & 
Westman, 2004).  Each study found a benefit in weight reduction in each diet but final analysis 
showed that no diet was superior to another in reducing weight in this population (Sacks et al., 
2009). 
More recently, focus was directed to using the glycemic index (GI) as a way both to 
reduce weight and to control diabetes in patients with type 2 diabetes (Ma et al., 2008).  The GI 
is a way to measure the effect that food has on glucose levels in the bloodstream.  Blood glucose 
can lead to an increase or decrease in hunger (Wolever, Jenkins, Jenkins, & Josse, 1991).  
Studies found a favorable amount of weight loss with these glycemic load controlled diets.  
Glycemic controlled diets have also demonstrated that a dietary intervention can be as useful as 
pharmacological agents in controlling postprandial hyperglycemia in some patients (Brand-
Miller, Hayne, Petocz, & Colagiuri, 2003) and can help to reduce weight in overweight adults 
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with high insulin secretion (Pittas et al., 2005).  These glycemic-controlled diets have also shown 
cardiovascular risk reduction in this population (McMillan-Price et al., 2006).  This means that 
many patients may be able to control their diabetes using a glycemic load controlled diet without 
the use of medication.   
Attrition in Weight Loss Programs 
 
Unfortunately, many lifestyle intervention programs are plagued with high rates of 
attrition.  Attrition from weight loss programs is estimated to be as high as 34-46% in hospital-
based and pharmacological interventions (Fabricatore et al., 2009; Wadden, Foster, Letizia, & 
Stunkard, 1992) and 25-70% in commercial weight reduction programs (Heshka et al., 2003; 
Volkmar, Stunkard, Woolston, & Bailey, 1981).  Factors correlated with attrition rates have been 
extensively studied but results have varied. 
In many studies, age appears to correlate consistently with increased attrition, with 
younger participants dropping out of studies more often than older participants (Dalle Grave et 
al., 2005).  One study conducted by Honas, Early, Frederickson, and O'Brian (2003) showed an 
increase in attrition rates in subjects who were not only younger (< 40 years old) but also 
divorced, were female, and were African American.  It has been theorized that patients in this 
group may have less time to dedicate towards weight loss; past research has shown that patients 
working full time or who have fewer hours to spend on weight loss will drop out at an increased 
rate (Gucciardi, Demelo, Offenheim, & Stewart, 2008; Huisman, Maes, Degucht, Chatrou, & 
Haak, 2009; Inelmen et al., 2005; Kolotkin & Moore, 1983).  Many patients cite practical 
reasons, such as work and family obligations, for their dropping out (Grossi et al., 2006).  
Younger patients may also not experience the negative health impact of their weight, or believe 
that they are immune to future complications. 
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Psychological variables were also explored in the research, from weight loss studies, to 
examine the effect of these variables on attrition although this data are less clear.  These studies 
showed an increase in attrition among patients reporting a high level of depressive symptoms at 
baseline (Fabricatore et al., 2009), or among patients having had a past history of depression 
(Clark, Niaura, King, & Pera, 1996).  Other researchers saw an increase in attrition if the subject 
had a history of emotional or physical health difficulties (Yass-Reed, Barry, & Dacey, 1993).   
Conflicting research has shown an increase in attrition rates in participants with lower 
levels of depression and a decrease in attrition in those participants reporting high rates of 
depression as well.  This may be due to the lower rates of obesity- related diseases in this 
subgroup, or possibly that the presence of mood disorders may actually work to reinforce the 
need for weight reduction and therefore decrease attrition rates in this population (Inelmen et al., 
2005).  From these studies, it is possible to see the powerful impact that psychological health can 
have on attrition from weight loss programs.  Even if patients are not currently experiencing 
symptoms, their histories of emotional instability may affect not only their current treatment, but 
also how they view their own progress in the program.   
Identifying the underlying causes of attrition has been difficult for researchers.  Many of 
the factors around increased attrition appear to be related to issues of self-efficacy and 
motivation.  Increased self-efficacy appears to decrease attrition rates in weight loss programs 
(Bernier & Avard, 1986), helping subjects to feel greater success in their weight loss even when 
results were less than what they expected (Mitchell & Stuart, 1984).  Much of this effect appears 
to be attributed to patients focusing more definitely on the “task” of weight control, instead of 
the “end goal” of weight control.  Focusing on the “task” of weight control (e.g., measuring 
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caloric values, meal planning, and journaling) helped patients stay with a weight loss lifestyle 
intervention longer.  
Low weight loss in the early stages of weight loss programs is often associated with 
attrition (Teixeira et al., 2002).  Patients often enter weight reduction programs expecting to lose 
a greater-than-average amount of weight.  When they fail to lose large amounts of weight early 
in the treatment (or, in fact, gain weight), they become discouraged and are more likely to drop 
out of the program (Fabricatore, 2007; Gucciardi, Demelo, Offenheim, & Stewart, 2008).  
Unrealistic expectation of weight loss is an issue that plagues all weight reduction programs.  
Although moderate reductions in weight can significantly decrease mortality in obese patients 
(Blackburn, 1995), most obese patients see the average reduction as highly unsatisfactory.  
Clients may report expected weight loss of twice the average reduction.  Foster, Wadden, Vogt, 
and Brewer (1997) found that the average dieter wished to lose about a third of their starting 
weight, which was three times more than the typical weight loss with the information being 
offered. Clients report dissatisfaction when treatment providers review the average expected 
weight loss numbers and will often declare that they will exceed the average result (Wadden et 
al., 2003).  These unrealistic goals for weight loss lead to feelings of failure and dissatisfaction 
when patients are unable to reach these goals (Teixeira et al., 2004).  Unrealistic expectations for 
weight loss have been linked to increased attrition rates in some studies (Dalle Grave et al., 
2005), but not others   (Fabricatore et al., 2007).  Unfortunately, as BMI increased, so did 
expected weight loss.  As the patient’s anticipated weight loss rose over the average 10% 
reduction, so did risk of attrition (Dalle Grave et al., 2004). 
The relationship between weight and self-esteem is complicated.  Many studies have 
explored the negative effect of weight on self-esteem, but determining how self-esteem affects 
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weight loss and dieting behavior is more complex.  A meta-analysis conducted by Miller and 
Downey (1999) showed a significant relationship between weight and self-esteem.  Examining 
71 different studies, they concluded that although there was a significant relationship between 
self-esteem and weight, it was difficult to determine the exact nature of that relationship.  They 
hypothesized that low self-esteem could be the result of being overweight, but also that low self-
esteem could contribute to weight gain.  This effect is especially true for binge eaters who may 
use food as a way to escape self-awareness, which they find painful.  The authors also speculated 
that efforts to control weight such as dieting and exercise could negatively affect self-esteem 
because of the perception that others will judge them for not being able to lose weight and that 
they lack willpower and self-discipline. 
Success in Weight Loss Programs 
 
Success in behavioral weight loss treatment with obese patients is usually measured by a 
reduction of around 5-10% of initial bodyweight.  Studies have found consistent predictors of 
success to be fewer previous dieting attempts (Martin, O'Neil, & Binks, 2002; Teixeira et al., 
2004), increased self-motivation, general feeling of self-efficacy, attendance at treatment 
sessions (Wadden  et al., 2009), and dieting autonomy (Williams, Grow, Freedman, Ryan, & 
Deci, 1996).  There appear to be a greater number of mixed results when examining the 
relationships between success and initial body weight/baseline BMI, body image, body size 
satisfaction (Teixeira et al., 2002), eating self-efficacy, realistic weight loss goals/expectations, 
and internal locus of control.  Only minor supportive evidence toward weight loss success has 
been seen when measuring factors such as exercise, self-efficacy, perceived barriers towards 
weight loss, obesity specific quality of life, perceived autonomy, and social support (Teixeira, 
Going, Sardinha, & Lohman, 2005). 
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In an obese population, increased weight loss early in the program has been found to be a 
predictor of success in weight reduction programs.  Wadden et al. (1992) found that patients who 
lost the greatest amount of weight during the first month of treatment lost the greatest amount of 
weight at the end of treatment.  However, Jeffery, Wing, and Mayer (1998) found that it was not 
the amount of weight lost, but the reaching of an early achievable goal (as identified by the 
participant) that resulted in greater weight reduction at the end of treatment.  Other studies have 
found that when the patient feels unsatisfied with the degree of early weight loss, the result is 
higher attrition and poorer outcome (Carels, Cacciapaglia, Douglass, Rydin, & O'Brian, 2003). 
Although setting and achieving early weight loss goals is important, studies have found 
that having a realistic goal in weight loss is important both for weight loss success and for 
reducing attrition from weight loss programs (Carels et al., 2003; Jeffery et al., 1998).  Realistic 
expectations set by most obesity programs inform patients that they can expect a 5-15% weight 
reduction.  Unfortunately, most patients set unrealistic goals expecting to lose 25% or more of 
their weight during the first year of treatment (Foster, Wadden, Vogt, & Brewer, 1997; Wadden 
et al., 2003).  Patients with unrealistic goals for weight loss may become discouraged by their 
average (or below average) weight losses during the treatment.  This may result in the patient 
becoming disillusioned, a higher rate of attrition, decreased motivation, and lower weight 
reduction at the end of treatment (Teixeira et al., 2002).  This decrease in self-efficacy may also 
increase the rate of relapse after treatment (Foster et al.). 
Evidence of how self-esteem may affect weight loss success and attrition is scarce and 
has resulted in mixed findings (Teixeira et al., 2005).  Evidence has been noted linking positive 
self-esteem with decreases in weight in the short term, but not in the long term.  Increased self-
esteem has been found to increase the duration of weight reduction maintenance (Nir & 
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Neumann, 1995).  People who are assured that they will lose more weight will be more likely to 
meet their weight loss goals (Dennis & Goldberg, 1996). 
Quality of life at baseline has been used to predict weight loss and attrition in a limited 
number of studies (Teixeira et al., 2005).  Overall results analyzing the effect of quality of life on 
treatment outcome has shown that lower quality of life scores at baseline typically result in a 
greater rate of treatment completion, but these clients are more likely to finish treatment with less 
weight loss (Teixeira et al., 2002).  Another study by Carels et al. (2003) showed an increased 
attrition rate in patients whose HRQOL scores did not improve by the 4
th
 week of treatment. 
Overall, it can be seen how weight loss motivation and self-efficacy are related to    
patients’ expected weight loss, to early treatment weight loss, to self-esteem, and to weight 
related quality of life.  These factors play an important role in obese individuals’ ability to make 
and maintain the behavioral changes prescribed in lifestyle modification interventions designed 
to help these individuals lose weight or control diabetes.  Unfortunately, much of the weight loss 
research does not look at attrition rates and success rates between obese patients with diabetes 
and obese patients without diabetes.  At this time, it appears that the current study will be the 
first of its kind to examine factors related to attrition and to success in a weight reduction 
program, specifically for patients diagnosed with type 2 diabetes. 
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Chapter Three: Hypotheses 
Overall Question 
 
The current study is guided by the following question: What factors predict weight loss success 
or predict attrition among people with type 2 diabetes who participate in a lifestyle modification 
program?  This question will be examined by analyzing baseline and outcome data from a 
randomized controlled trial that compared weight loss and diabetes control among obese patients 
with type 2 diabetes who were randomized to receive either a low-fat or low-glycemic load diet 
as part of a lifestyle modification program.  Because each group in the original study was 
required to fulfill the same lifestyle modification program (e.g., same caloric content, weekly 
groups, etc.) the two study groups will be combined into one single group for this study. 
 
Hypothesis 1 
 
Ho: Early weight loss (5
th
 week) will not significantly predict successful weight loss or attrition. 
H1: Early weight loss (5
th
 week) will significantly predict successful weight loss and attrition at 
40 weeks, i.e., subjects who lost the greatest amount of weight at week 5 are expected show a 
lower rate of attrition and show a weight reduction of ≥5% at week 40. 
Rationale: Subjects who show early success in their weight loss will be more motivated to 
continue with the program, which will lead to greater weight loss at 40 weeks. 
 
Hypothesis 2 
 
Ho: Unrealistic expectations of weight loss at the beginning of the diet will not significantly 
predict attrition or weight loss success at 40 weeks. 
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H1: Ambitious expectations for weight loss (greater than 20% of starting weight) will negatively 
predict weight loss and will predict attrition in both groups, i.e., subjects who hope to achieve a 
reduction of over 20% of their starting weight will display a higher risk of attrition and lower 
rate of success.  
Rationale: Subjects who believe their efforts are not leading to desirable results are more likely 
to reduce or discontinue those efforts, leading to attrition and lower weight loss. 
 
Hypothesis 3 
 
Ho: Baseline self-esteem will have no significant effect on risk of attrition or of success. 
H1: Baseline self-esteem will predict weight loss and attrition, i.e., subjects who report higher 
levels of self-esteem will be more likely to achieve weight loss success, as measured by a ≥5% 
weight reduction and will be less likely to drop out of the study. 
Rationale: Subjects who report higher self-esteem will be more likely to follow through with a 
regimented program for weight reduction.  These subjects will be less likely to drop out of the 
program if they deviate from their eating schedule or do not lose expected weight during any part 
of the trial. 
 
Hypothesis 4 
 
Ho: Baseline quality of life will not predict attrition or success. 
H1: Subjects with lower baseline quality of life will lose more weight and show lower risk of 
attrition. 
Rationale: Subjects who have lower quality of life scores will be more motivated to lose weight 
and stay on a structured program because of the difficulties they are facing from their obesity.  
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Thus, subjects who report lower quality of life will show less risk of attrition and be more likely 
to lose ≥5% of baseline weight at 40 weeks. 
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Chapter Four: Methods 
Overview 
 
This chapter describes the methodology of the current study, including its design, 
participants, procedures, and potential benefit to others.   
Design and Design Justification 
 
The current study will utilize an archival-data design. The data were originally collected 
as part of a randomized clinical trial conducted at the University of Pennsylvania Center for 
Weight and Eating Disorders (Fabricatore et al., 2011).  This study examined the differences in 
weight loss and glycemic control among overweight and obese individuals diagnosed with type 2 
diabetes who participated in a lifestyle modification program.  The subjects were randomly 
assigned to receive a conventional Low-Fat (LF) diet or an alternative Low-Glycemic Load (LG) 
diet.   The trial included 40 weeks of treatment and an additional 52 weeks of follow-up. Only 
data from baseline and the end of treatment (i.e., weeks 0 and 40, respectively) are used in the 
current analysis.  
 Inclusion/Exclusion Criteria 
 
The subjects who were eligible to participate in the original trial must have had a 
diagnosis of type 2 diabetes, verified by a treating physician.  Subjects must have a BMI of 27 -
45 kg/m
2
 with weight  136 kg (300 lbs.), capacity to provide written informed consent, 
willingness and commitment to return for all clinic visits, complete all study-related procedures, 
and live within a 30 mile radius of the clinic.  Subjects also must have a systolic blood pressure 
between 90 and 160 mm Hg, inclusive and a diastolic blood pressure between 65 and 100 mm 
Hg, inclusive, as well as a resting heart rate between 65 and 90 beats per minute, inclusive.   
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Subjects were excluded from the study if they had a recent (i.e., within 1 year) 
myocardial infarction, unstable angina, malignant arrhythmias, cancer (active or in remission for 
fewer than 5 years), history of cerebrovascular, renal, or hepatic disease, history of seizures, 
protein wasting diseases (e.g., Cushing’s syndrome), uncontrolled hypertension (> 160/100 mm 
Hg), type 1 diabetes, uncontrolled thyroid disease, pregnancy or lactation, electrolyte 
abnormalities, clinically significant psychosocial impairment (principally, major depression) or 
treatment with steroids.  
Participants 
 
The participants of this study were those subjects who enrolled at baseline and completed 
all baseline questionnaires. According to the study, 79 subjects (N = 79) were randomized and 
completed baseline assessment.  All subjects were between the ages of 31 and 65 and had a BMI 
of at least 27 kg/m
2
.  Subjects completed questionnaires at pre-baseline, at baseline, at 20 weeks, 
and at 40 weeks of treatment.  Weight was also recorded at all visits. 
Screening Procedures to Determine Inclusion/Exclusion Criteria 
 
Patients who expressed interest were contacted by a research assistant who screened 
patients by telephone for inclusion and exclusion criteria.  Qualified patients were mailed the 
Weight and Lifestyle Inventory (WALI).  They were scheduled for an initial visit during which 
time they were given the full description of the study, provided written informed consent to 
participate, screened for weight, BMI, blood pressure, and pulse.  Consenting individuals were 
then given an appointment for baseline assessment, a packet of questionnaires, and a 3-day food 
journal to be completed prior to assessment.  Participants were also given a referral to a 
physician who performed a physical examination and history.  Physicians were informed that 
subjects would be enrolled in the study with the expectation that medications will be held 
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constant during the trial; with the exception of changes required in response to medical 
emergency (i.e., reductions in insulin to reduce the risk of hypoglycemia).   
Recruitment 
 
Participants were recruited from public service announcements, notices in local media, 
referrals from local physicians, the Pennsylvania Integrated Clinical and Administrative 
Research Database (PICARD), direct mailing service Aldata, and the website Craigslist. 
Plan for Informed Consent Procedures 
 
All subjects provided informed consent to participate in the randomized controlled trial.  
Consent to be included in the proposed analysis was not required.     
Measures 
 
The current study will analyze initial baseline data from the study conducted by Dr. 
Fabricatore and colleagues.  The baseline measurements used were the self-esteem question 
listed in the WALI, reported expected weight loss listed in the WALI, IWQoL-Lite measurement 
at baseline, and measured weight loss at 5 weeks.  The WALI is self-report questionnaire that 
examines biological, environmental, social, psychological, and temporal factors related to weight 
(Wadden & Foster, 2003).  The WALI has good test retest reliability for items measuring self-
esteem and self-perception (r = .69 - .97); the WALI self-esteem items correlated with the 
Rosenberg Self Esteem Scale (r = .62) (Wadden et al., 2006). 
The Impact of Weight on Quality of Life (IWQoL) measures weight-related quality of 
life issues including weight’s impact on physical functioning, self-esteem, sexual life, public 
distress, and work (Kolotkin, Crosby, Kosloski, & Williams, 2001; Wadden & Phelan, 2002).  
The Impact of Weight on Quality of Life - Lite (IWQOL-Lite) was later developed as a brief 
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assessment of quality of life in the obese population and has been demonstrated to be a valid and 
reliable measure with this population (Kolotkin & Crosby, 2002).   
Procedure 
 
The current study was conducted using original data from the study’s principal 
investigator, Anthony N. Fabricatore, Ph.D.  Permission was obtained to use the study’s de-
identified data set; the WALI data were analyzed to look for differences in baseline self-esteem 
as a predictor of attrition and of successful weight loss at 40 weeks.  The IWQoL-Lite was 
examined to compare baseline differences in the attrition group and in the success group to see if 
quality of life affected the rate of attrition and the rate of success in the completion group at 40 
weeks.  Expected weight loss data (taken from the WALI) were calculated as a percentage from 
initial weight and were used to estimate if expected weight loss affected attrition and affected 
success.  Finally, weight loss data at week 5 were examined as a percentage of weight and 
examined as a predictor for success and as a predictor for attrition in this study. 
Analysis of Risk/Benefit Ratio 
 
Potential Risk to Participants  
 
There is no risk to the subjects of the current study due to its archival-data design. 
Potential Benefit to Participants 
 
There is no benefit to the subjects of the current study due to its archival-data design. 
Potential Benefit to Others  
 
The current study may potentially benefit others who have been diagnosed with type 2 
diabetes and are trying to lose weight.  Data have shown that a modest decrease in weight can 
have significant beneficial effects on health.  Because loss of motivation and self-efficacy can 
significantly affect individuals’ willingness to stay with a weight loss plan and be successful, 
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information on how to identify (and potentially address) these issues may increase the likelihood 
of success and decrease attrition rates in weight loss programs that enroll diabetic patients. 
Procedure for Maintaining Confidentiality 
 
The subjects’ charts will remain in a locked filing cabinet at the Center for Weight and 
Eating Disorders at the University of Pennsylvania to ensure confidentiality of the subjects’ 
information.  Data that has been provided will be de-identified and no information will be 
released regarding the identities of the participants involved.  
ATTRITION AND SUCCESS IN WEIGHT  36 
Chapter Five: Results 
Statistical Analysis 
 
Analysis of the data was conducted in order to test the listed hypotheses.  Dependent 
variables in this study consist of attrition and success.  Attrition was defined as, “Subject did not 
complete the first 40 weeks of the study” and divided into two categories, “dropped out before 
the first 40 weeks,” and “did not drop out before 40 weeks.”  Success was measured similarly by 
dividing this category into two groups.  Participants were classified as successful if they 
achieved and maintained at least a 5% reduction in initial body weight at week 40.  Participants 
were deemed unsuccessful if their weight loss was less than 5% of their initial weight.  Baseline 
weight values were carried forward for participants who dropped out of treatment.  Thus, anyone 
who prematurely discontinued treatment was classified as unsuccessful, regardless of their 
weight loss at the time of attrition.  
 The first hypothesis measured how 5
th
 week weight loss affected rate of attrition and rate 
of success in the study.  Participants were categorized into “low,” “medium,” and “high” tertiles 
of weight loss at week 5.  The three-level early weight loss variables were examined in separate 
logistic regression analyses with attrition and success as the outcome variables.  Logistic 
regression yielded the odds of success or attrition (depending on the outcome variable) for those 
in the “medium” and “high” categories of early weight loss, compared with those in the “low” 
category of early weight loss.  
 The second hypothesis examined the relationships of weight loss expectations both to 
success and to attrition.  Weight loss expectation was divided into three categories: low weight 
reduction was labeled as “up to 20% reduction from baseline”; medium weight reduction was 
defined as “20-30% of baseline weight at 40 weeks”, and high weight loss was defined as “>30% 
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reduction of baseline weight.”  These levels of expectation were again analyzed against the two 
dependent variables of attrition and success using a logistic regression.  This analysis compared 
the odds of attrition and the odds of success among those in the “medium” and “high” categories 
of expected weight loss, compared with those in the “low” category of expected weight loss. 
 The third hypothesis examined the relationships of self-esteem at baseline both to 
attrition and to success.  Self-esteem was assessed with a single item on the WALI: “In general I 
am…” Responses were reported on a five-point scale, in which 1= “very happy with who I am”, 
2 = “happy with who I am”, 3 = “ok with who I am but have some mixed feelings”, 4 = 
“unhappy with who I am”, 5 = “very unhappy with who I am.”  Participants who scored 1 or 2 
were categorized as having “positive” self-esteem, whereas those who scored 4 or 5 were 
classified as having “negative” self-esteem.  Participants who scored 3 were classified as a 
separate group, defined as having “mixed” self-esteem.  These three levels of self-esteem were 
analyzed against the dependent variables, using a logistic regression to examine how identified 
self-esteem may predict success and attrition at 40 weeks.  Again the groups were compared, 
looking at the “mixed” and “negative” self-esteem groups against the “positive” self-esteem 
group to obtain an odds ratio of the relationship between self-esteem to success and self-esteem 
to attrition.  
Finally, the fourth hypothesis examined how quality of life, measured by the IWQOL-
Lite, relates to rate of attrition and success at 40 weeks.  Full-scale data from the IWQOL-Lite 
were normed and divided into two groups.  Subjects were placed into the “impaired quality of 
life” group if they scored at least one standard deviation above the scale’s norm.  All other 
subjects were considered in the “unimpaired quality of life.” These two groups were analyzed 
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against the dependent variables, using a logistic regression to examine the predictive ability of 
each group to the dependent variables of success and attrition. 
Results 
 
In the early analysis, the predictor variables of early weight loss (5
th
 week), weight loss 
goals, quality of life, and self-esteem were correlated to determine the independence of these 
predictors.  As shown in table 1, the correlations among the predictors indicated no overlap and 
each variable was analyzed against the dependent variables of attrition and success.  Each 
variable was analyzed, using logistic regression to calculate the odds ratios of the independent 
variables’ ability to predict the dependent variable.   
Table 1 
 
Correlation of Predictors 
 
 Constant Quality of Life Self Esteem Weight Loss Goal 5th Week Weight Loss 
Constant 1.000 -.839 -.527 -.426 -.222 
Quality Of Life -.839 1.000 .377 .255 -.078 
Self Esteem -.527 .377 1.000 -.013 -.073 
Wt Loss Goal -.426 .255 -.013 1.000 -.330 
5th Wk Wt Loss -.222 -.078 -.073 -.330 1.000 
 
In the first hypothesis examining early weight loss, the data were divided into 3 tertiles 
classified as low (lost less than 0.48% of initial body weight), medium (lost 0.49% to 2.15%) and 
high (lost 2.16% or more).  Attrition rates in these groups were 65.4%, 29.6%, and 15.4% 
respectively (see table 2).  The lowest tertile was used as a reference group to see if the medium 
and high tertile were significant predictors of retention at week 40.  As compared with subjects 
in the low weight tertile, those in the medium and high tertiles were significantly less likely to 
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drop out of the study (OR = 0.096, 95% CI: 0.025, 0.367; OR = 0.223, CI: 0.070, 0.708), 
respectively.  Said differently, the odds of dropping out of the study for those in the low tertile of 
early weight loss were nearly five and ten times higher than those in the medium and high 
groups, respectively  (OR = 4.489; 95% CI: 1.413, 14.246;  OR = 10.389; 95% CI: 2.728, 
39.560) (see table 3). 
Table 2 
 
Crosstabulation of Early Weight Loss and Attrition 
 
 Did Patient Complete 40 Weeks of Treatment? 
  No Yes Total 
Weight Gained or Lowest Loss at Week 5 Count 17 9 26 
% Within Tertile 65.4% 
34.6% 100.0% 
Medium Tertile of Weight Loss at Week 5 Count 8 
19 27 
% Within Tertile 29.6% 
70.4% 100.0% 
Highest Tertile of Weight Loss at Week 5 Count 4 
22 26 
% Within Tertile 15.4% 
84.6% 100.0% 
Total Count 29 
50 79 
% Within Tertile 36.7% 
63.3% 100.0% 
 
Table 3 
 
Early Weight Loss and Attrition Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Weight Gained or Lowest Loss at Week 5   13.236 2 .001    
Medium Tertile of Weight Loss at Week 5 1.501 .590 6.482 1 .011 4.486 1.413 14.246 
Highest Tertile of Weight Loss at Week 5 2.341 .682 11.773 1 .001 10.389 2.728 39.560 
Constant -.636 .412 2.380 1 .123 .529   
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In the second analysis examining overall weight loss at week 40, the same tertile 
breakdown was made but was analyzed against the dependent variable of losing 5% of weight or 
more at week 40.  Success rates in these groups were 11.5%, 33.3%, and 57.7% respectively (see 
table 4).  Again using the lowest tertile as a reference group, patients in the middle group were 
not significantly more likely to achieve success (i.e., to lose at least 5% of their weight) at week 
40 (OR = 3.833, CI: .904, 16.259).  The group that lost the greatest amount of weight at week 5 
were significantly more likely to succeed in losing at least 5% of their weight at week 40 (OR = 
10.455, CI: 2.495, 43.808) (see table 5).  
Table 4 
 
Crosstabulation of Early Weight Loss and Success 
 
 Did Patient Lose 5% or Greater Weight 
  No Yes Total 
Weight Gained or Lowest Loss at Week 5 Count 23 3 26 
% Within Tertile 88.5% 11.5% 100.0% 
Medium Tertile of Weight Loss at Week 5 Count 18 9 27 
% Within Tertile 66.7% 33.3% 100.0% 
Highest Tertile of Weight Loss at Week 5 Count 11 15 26 
% Within Tertile 15.4% 84.6% 100.0% 
Total Count 29 50 79 
% Within Tertile 42.3% 57.7% 100.0% 
 
Table 5 
 
Early Weight Loss and Success Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Weight Gained or Lowest Loss at Week 5   
10.657 2 .005 
   
Medium Tertile of Weight Loss at Week 5 
1.344 .737 3.322 1 .068 3.833 .904 16.259 
Highest Tertile of Weight Loss at Week 5 
2.347 .731 10.308 1 .001 10.455 2.495 43.808 
Constant 
-2.037 .614 11.011 1 .001 .130   
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The second hypothesis addressed how weight loss goals at baseline were related to 
success and attrition at week 40.  Participants’ weight loss goals (as % of initial weight) were 
divided into three categories of low weight loss goal (0% to 20%), medium (>20% to 30%), and 
high (> 30%).  Attrition rates in these groups were 31.6%, 31.2%, and 47.8%, respectively (see 
table 6).  Weight loss goals were entered into logistic regression analyses with attrition and 
success at week 40 as the dependent variables.  Using the low goal group as a reference group, 
there did not appear to be a significant increase in the odds of attrition in the medium group (OR 
= 1.015 CI: .299, 3.448) or in the high goal group (OR = .503 CI: .142, 1.787), based on the 
goals set at baseline.  In other words, in this population setting a higher goal at baseline did not 
significantly increase the odds of dropping out at week 40 (see table 7). 
Table 6 
 
Crosstabulation of Weight Loss Goals and Attrition  
 
 Did Patient Complete 40 Weeks of Treatment? 
  No Yes Total 
Low Weight Loss Goal Count 6 13 19 
% Within Tertile 31.6% 68.4% 100.0% 
Medium Weight Loss Goal Count 10 22 32 
% Within Tertile 31.2% 68.8% 100.0% 
High Weight Loss Goal Count 11 12 23 
% Within Tertile 47.8% 52.2% 100.0% 
Total Count 27 47 74 
% Within Tertile 36.5% 63.5% 100.0% 
 
Table 7 
 
Weight Loss Goals and Attrition Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Low Weight Loss Goal   
1.825 2 .402 
   
Medium Weight Loss Goal 
.015 .624 .001 1 .980 1.015 .299 3.448 
High Weight Loss Goal 
-.686 .646 1.127 1 .288 .503 .142 1.787 
Constant 
.773 .494 2.454 1 .117 2.167   
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Similarly, no significant effect of weight loss goal was seen when looking at the 
dependent variable of success in a weight loss of 5% or greater at week 40.  Success rates in 
these groups were 31.6%, 50.0%, and 21.7%, respectively (see table 8).  Using the low weight 
loss goal as the reference group, the middle goal group did not show an increased odds ratio 
weight loss success (OR = 2.167, CI: 0.659, 7.121) nor did the highest goal group (OR = 0.602, 
CI: 0.151, 2.404) (see table 9). 
Table 8 
 
Crosstabulation of Weight Loss Goal and Success 
 
 Did Patient Lose 5% or Greater Weight? 
  No Yes Total 
Low Weight Loss Goal Count 13 6 19 
% Within Tertile 68.4% 31.6% 100.0% 
Medium Weight Loss Goal Count 16 16 32 
% Within Tertile 50.0% 50.0% 100.0% 
High Weight Loss Goal Count 18 5 23 
% Within Tertile 78.3% 21.7% 100.0% 
Total Count 47 27 74 
% Within Tertile 63.5% 36.5% 100.0% 
 
Table 9 
 
Weight Loss Goal and Success Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Low Weight Loss Goal   
4.691 2 .096 
   
Medium Weight Loss Goal 
.773 .607 1.622 1 .203 2.167 .659 7.121 
High Weight Loss Goal 
-.508 .707 .516 1 .472 .602 .151 2.404 
Constant 
-.773 .494 2.454 1 .117 .462   
 
In the third hypothesis examining self-esteem, participants were categorized as having 
positive, mixed, or negative self-esteem.  Only 91.1% of the baseline subjects completed the 
WALI item assessing self-esteem (n = 72).  Attrition rates in the three self-esteem groups were 
35.6%, 36.8%, and 25.0%, respectively (see table 10).  The positive self-esteem category was 
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used as a reference group to see if the mixed and negative self-esteem groups were significant 
predictors of attrition at week 40.  As compared with the positive self-esteem group, there did not 
appear to be any significant effect on odds of attrition either in the mixed self-esteem group (OR 
= 0.604, CI: 0.109, 3.350) or in the negative self-esteem group (OR = 0.571, CI: 0.090, 3.641) 
(see table 11).   
Table 10 
 
Crosstabulation of Self Esteem and Attrition 
 
 Did Patient Complete 40 Weeks of Treatment? 
  No Yes Total 
Positive Self Esteem Count 16 29 45 
% Within Tertile 35.6% 64.4% 100.0% 
Mixed Self Esteem Count 7 12 19 
% Within Tertile 36.8% 63.2% 100.0% 
Negative Self Esteem Count 2 6 8 
% Within Tertile 25.0% 75.0% 100.0% 
Total Count 25 47 72 
% Within Tertile 34.7% 65.3% 100.0% 
 
Table 11 
 
Self Esteem and Attrition Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Positive Self Esteem   
.379 2 .828 
   
Mixed Self Esteem 
-.504 .874 .333 1 .564 .604 .109 3.350 
Negative Self Esteem 
-.560 .945 .351 1 .554 .571 .090 3.641 
Constant 
1.099 .816 1.810 1 .178 3.000   
 
In the second analysis for overall weight loss at week 40, the same category breakdown 
was made but was analyzed against the dependent variable of weight loss of 5% or more at week 
40.  Success rates in these groups were 37.5, 42.1%, and 35.6% respectively (see table 12).  
Again, using the positive self-esteem category as a reference group, no significant odds ratio was 
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seen in the mixed self-esteem group (OR = 0.920, CI: 0.194, 4.359), or the negative self-esteem 
group (OR = 1.212, CI: 0.222, 6.612) (see table 13). 
 
Table 12 
 
Crosstabulation of Self Esteem and Success 
 
 Did Patient Lose 5% Weight or Greater? 
  No Yes Total 
Positive Self Esteem Count 5 3 8 
% Within Tertile 62.5% 37.5% 100.0% 
Mixed Self Esteem Count 11 8 19 
% Within Tertile 57.9% 42.1% 100.0% 
Negative Self Esteem Count 29 16 45 
% Within Tertile 64.4% 35.6% 100.0% 
Total Count 45 27 72 
% Within Tertile 62.5% 37.5% 100.0% 
 
Table 13 
 
Self Esteem and Success Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Positive Self Esteem   
.244 2 .885 
   
Mixed Self Esteem 
-.084 .794 .011 1 .916 .920 .194 4.359 
Negative Self Esteem 
.192 .866 .049 1 .824 1.212 .222 6.612 
Constant 
-.511 .730 .489 1 .484 .600   
 
In the fourth hypothesis examining weight related quality of life, the data were divided 
into two groups, unimpaired quality of life and impaired quality of life.  These groups were taken 
from within the sample by looking at the mean score on the IWQOL-Lite and using 1 standard 
deviation above the mean to identify the impaired group.  Attrition rates for the impaired and 
unimpaired groups were 33.3% and 37.7% respectively (see table 14).  The unimpaired group 
was used as a reference group to see if the impaired group was a significant predictor of retention 
at week 40.  As compared with the unimpaired group, the impairment did not significantly affect 
the attrition rate in this population (OR = 1.211 CI: 0.400, 3.667) (see table 15). 
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Table 14 
 
Crosstabulation Quality of Life and Attrition 
 
 Did Patient Complete 40 Weeks of Treatment? 
  No Yes Total 
Impaired Quality of Life Count 6 12 18 
% Within Tertile 33.3% 66.7% 100.0% 
No Impaired Quality of Life Count 23 38 61 
% Within Tertile 37.7% 62.3% 100.0% 
Total Count 29 50 79 
% Within Tertile 36.7% 63.3% 100.0% 
 
Table 15 
 
Quality of Life and Attrition Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Impaired Quality of Life 
.191 .566 .114 1 .735 1.211 .400 3.667 
Constant 
.502 .264 3.612 1 .057 1.652   
 
In the second analysis for overall weight loss at week 40, the same breakdown was made 
but was analyzed against the dependent variable of weight loss of 5% or more at week 40.  The 
success rates for the impaired and unimpaired groups were 33.3% and 34.4%, respectively (see 
table 16).  Again using the unimpaired group as a reference group, quality of life impairment did 
not significantly predict success at week 40 (OR = 0.952, CI: 0.313, 2.899) (see table 17). 
Table 16 
 
Crosstabulation of Quality of Life and Success 
 
 Did Patient Lose 5% Weight or Greater? 
  No Yes Total 
Impaired Quality of Life Count 12 6 18 
% Within Tertile 66.7% 33.3% 100.0% 
No Impaired Quality of Life Count 40 21 61 
% Within Tertile 65.6% 34.4% 100.0% 
Total Count 52 27 79 
% Within Tertile 65.8% 34.2% 100.0% 
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Table 17 
 
Quality of Life and Success Regression Table 
 
       95.0% C.I for OR 
 B S.E. Wald df Sig. Exp(B) Lower Upper 
Impaired Quality of Life 
-.049 .568 .007 1 .932 .952 .313 2.899 
Constant 
-.644 .269 5.717 1 .017 .525   
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Chapter Six:  Discussion 
The current archival study was designed to examine baseline and early treatment factors 
that were related to attrition and success in a weight reduction program with patients diagnosed 
with type 2 diabetes.  Prior studies have shown mixed results when trying to predict weight loss 
program success and attrition.  This study examined not only the combination of obesity and 
diabetes but also how this combination may present a more complicated landscape when 
predicting success and attrition in patients attempting to lose weight.  At this time it appears that 
the current study is the first to examine these factors in this distinct population.  Specifically, the 
researcher looked at quality of life, expected weight loss, self-esteem, and early weight loss in 
relation to attrition and success, defined as a 5% or greater reduction in initial weight.   
Summary and Integration of Results 
 
Examining early weight reductions effect on attrition and success in this population, the 
group that lost the greatest amount of weight at week 5 was more than 10 times more likely than 
the lowest weight loss group to stay in the study until week 40.  The medium weight loss group 
was more than 4 times more likely to stay in the study until week 40.  Losing weight early in a 
program can serve as motivation to stay in the program longer, even if success begins to waiver 
over time.   
Examining success in the current study population, this researcher again saw a similar 
finding.  Compared with the group that lost the least amount of weight at week 5, the group that 
lost the greatest amount of weight at week 5 was also 10 times more likely to lose at least 5% of 
their weight at week 40.  
The next variable examined was weight loss goals set at baseline.  As discussed earlier, 
many patients tend to set overly ambitious weight loss goals (Wadden et al., 2003), and when 
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they are unable to reach these goals, they can become discouraged and will sometimes give up 
(Teixeira et al., 2002).  The current study did not find any significant decrease in attrition when 
comparing subjects who set low early weight loss goals compared with subjects who set high 
early weight loss goals.  There were consistent results when comparing success rates in this 
population.  Setting ambitious or reasonable goals for weight loss did not significantly predict 
success or attrition in this sample.  This may not be due to the lack of a correlation, but might 
instead attributed to the limited data from the small sample size.  Because of the small sample 
size in the study, in order to achieve an even spread within each tertile, there was only a ~8% 
difference in weight goals between the lowest tertile of expected weight loss and the highest 
tertile.  This small spread and limited sample reduced the power of the analysis and may have 
contributed to the null finding.  It should also be noted that the category thresholds used in this 
study were somewhat generous.  In order to achieve a normal spread of data, cutoffs were set at 
20%, 30%, and 30+%, respectively; however, 5-10% is typically reasonable, 10-20% is 
ambitious and 20+% is very ambitious.  However, breaking up groups in this manner was not 
possible due to left skewing in the distribution of expectations. 
The third hypothesis of self-esteem’s effect on success and attrition was also unsupported 
statistically.  In this study, the subject’s self-report of self-esteem did not appear to affect their 
levels of attrition or success in the study.  Again, this may have been the result of the small 
sample size in the study. Only 8 subjects self- reported having low self-esteem and 45 reported 
high self-esteem (with the rest reporting “mixed self-esteem”).   
Because of the changes in appetite that can result from altering diabetes medication, 
many patients with diabetes experience a decreased perception of control over their weight loss.  
This perceived loss of control may lead to feelings of helplessness or hopelessness in their ability 
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to lose weight.  These feelings of hopelessness or helplessness will at times cloud the picture of 
self-esteem and the way in which patients with type 2 diabetes see their ability to lose weight 
(Delahanty et al., 2007).  These patients may also blame themselves for their diabetes, leading to 
more negative feelings and decreased self-esteem. 
Another explanation of the reason why self-esteem may not have had a significant effect 
on this sample is that self-esteem was measured at baseline but was not continuously monitored 
throughout the study.  If a subject initially rated himself or herself as having low self-esteem, but 
then began to see success in his or her weight loss, the rating of self-esteem may have improved 
dramatically (with the opposite occurring for patients who gained weight).  Because self-esteem 
was not measured consistently throughout the study, it was impossible to see if this effect was 
true or not and therefore this may be an error both in measurement and in theory. 
Finally, the fourth hypothesis measuring weight-related quality of life also failed to show 
significant results.  In this hypothesis, this researcher examined how impaired quality of life may 
influence attrition and may influence success in weight reduction.  Impaired quality of life failed 
to significantly predict success and attrition in this population.  This may have been due to an 
error in measurement (this will be discussed later) or in calculating the actual impairment in 
quality of life.  In the current study, quality of life was determined by norming the IWQOL-Lite 
data and using the group that fell one standard deviation above the norm as the impaired group.  
Typically, patients who already experience the negative effects of type 2 diabetes report a lower 
quality of life.  This sample may not have been representative of a typical diabetic sample 
because the level of impairment is lower than what has been seen in other studies.  Kolotkin & 
Crosby (2002) looked at the IWQOL-Lite data in a community sample and found that the mean 
level of impairment was 52.2 with a standard deviation of ±21.3.  These numbers were obtained 
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from a community sample of obese patients seeking treatment in which the mean BMI = 27.4 
and the mean age was 38.1.  In the current study sample, the mean age was 52, mean BMI = 
36.27, and mean IWQOL-Lite score was 62.01 ± 22.16.  Because a positive linear relationship 
exists between quality of life, age, and BMI, it is expected that the current sample would report a 
lower quality of life, exceeding the rating seen in the current sample.  It should also be noted that 
the sample used in the Kolotkin & Crosby (2002) study was not taken from a diabetic 
population.  The fact that the current sample did not significantly differ in terms of quality of life 
scores despite the fact that the subjects were older, reported higher BMIs, and were also 
diagnosed with diabetes shows that the current study sample may not accurately reflect the 
impairment typically seen in an obese type 2 diabetic population.  One reason that the current 
study sample may not have accurately reflected the true level of impairment that is typically seen 
may be due to selection bias, because subjects were not included in the study if their weight 
exceeded 300lb, had uncontrolled medical issues, or significant psychological problems.  
Significantly, there was also the possibility of a certain level of self-selection because patients 
were told before the study began that they were expected to exercise and follow an eating 
program with no monetary compensation.  Statistically, only 18 people fell into the impaired 
quality of life category (22.8%); this may not have been a large enough sample size to see 
significant results.  
The results of this study demonstrate the fact that there continues to be a lot of variability 
in the factors that can predict success and attrition in lifestyle modification programs with 
overweight and obese patients.  These results mirror past research findings that patients with type 
2 diabetes do not appear to differ significantly from patients without type 2 diabetes, and the 
same inconsistent findings that are seen in the general obese population also appear in this 
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population.  Of note, many of the null results in this study may be attributed to small population 
size and weak statistical power.   
The current study succeeded in replicating the finding that early weight loss may increase 
motivation and lead to patients staying in the treatment longer and experiencing greater success. 
However, this study failed to reveal an increase in odds when examining self-esteem, weight loss 
goals, and quality of life. 
Integration of findings with past literature 
 
The significant relationships between early weight loss and increased success and 
decreased attrition that were found in this study converged with much of the existing data on 
weight loss.  This finding was not surprising because it mirrored past results by Fabricatore, 
2007; Gucciardi, Demelo, Offenheim, & Stewart, 2008, who saw that low early weight loss often 
led to early attrition from weight reduction programs.  This finding suggests that patients with 
type 2 diabetes may also benefit from early success in their program and that they will be driven 
by the same factors as the non-diabetic population.  This convergence of the current research 
with past findings is also reflected in the null findings on many of the other variables.  Obesity 
research has shown inconsistent findings in predicting success and attrition with this population 
and it is not surprising that this study produced the same results.  Because this is only an early 
snapshot of how the type 2 diabetic population may compare with the general obesity population, 
these early findings do contribute to the literature in the  ways in which these two populations 
may not differ significantly in what works and what does not work in lifestyle modification 
programs. 
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Implications of Findings 
 
Although the results of several analyses did not support rejection of the null hypothesis, 
the finding that early weight loss did significantly predict a decrease in attrition and an increase 
in success in the obese type 2 diabetic population is promising.  This discovery will allow 
researchers and clinicians to encourage early success in studies (as opposed to concentrating only 
on long term loss) and also provide additional support to patients who are struggling early in the 
program.  Researchers may also increase support by making specific changes, or may encourage 
participants to focus on the task of weight loss instead of focusing on the weight loss numbers in 
order to prevent patients from becoming discouraged and abandoning their efforts.  
Demonstrating that the type 2 diabetes population may respond similarly to early success just as 
the non-type 2 diabetic population means that treatment providers can continue to work with 
both of these populations simultaneously and may not need to provide separate protocols when 
treating individuals with and without type 2 diabetes. 
In the expected weight loss group, the null finding may also be attributed to actual non-
significant predictive value with this population.  In the type 2 diabetic population, changes in 
medication can often lead to changes in weight and appetite (Anthony et al., 2006).  This 
population may therefore be immune to the effects of goal setting because of lowered 
expectations of success due to a history of medication changes affecting their success and failure 
(Looker, Knowler, & Hanson, 2001).  The type 2 diabetes population may experience a type of 
“learned helplessness” over their treatment which can adversely affect their self-esteem and self-
efficacy.  If this does, in fact, become the case, programs treating the obese type 2 diabetic 
population may find more success by focusing on the history of medication treatment, past 
dieting history, attitude toward weight loss, and other social influences to conceptualize the 
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patient’s schema.  By obtaining this schema information, programs are well-situated to educate 
patients and to examine accurate expectations when setting long and short-term goals in order to 
provide more positive feedback, and instill hope, when necessary. 
Limitations 
 
There were many limitations in this study; specifically, that this researcher used an 
archival data set and was therefore limited to the data collected at baseline.  If more precise 
measures for quality of life, self-esteem, and expected weight loss were used, it may have added 
significantly to the information and more accurately determined underlying differences in this 
population. 
The self-esteem measurement in this study relied on one self-report question in the WALI 
(Wadden & Foster, 2003).  Participants may have been unwilling to divulge their negative self-
image due to embarrassment or fear that it could disqualify them from the study.  As referenced 
earlier, the patient’s motivation may actually change throughout the study as they fail or as they 
succeed in losing weight and controlling their diabetes, thus confirming or challenging their 
current self-image.  Individuals who initially rated themselves as having poor or even mixed self-
esteem may have some initial success in the treatment and suddenly began feeling more 
confident and had improved self-efficacy.  Unfortunately, in this study they would still stay 
classified in the “poor self-esteem” group despite the fact that their subjective self-esteem rating 
may have changed.  This data point could have been improved by comparing changes in 
subjective self-esteem ratings over time, but because these ratings were never collected, it was 
not possible to dissect from the data.  This is not suggesting that actual self-esteem may have 
changed because of the weight loss, but that their subjective measurement may have changed.  
This error in measurement may have also occurred when examining weight-related quality of 
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life.  As mentioned earlier, ratings of self-esteem and quality of life may change depending on 
success or failure in following a program.  Using standardized scores may have shown a different 
result, but because of the limited sample size and variability of the dataset, testing this was not 
possible. 
The second major limitation to this study was the relatively small number of subjects 
enrolled in the original study (N = 79).  This significantly reduced the power of the statistical 
analyses required and made finding significance more difficult.  Although many of the results 
came close to being significant, the limited number of subjects may have interfered.  The 
statistical power as related to the limited sample size will be covered later in this section. 
Another limitation was the number of self-report scales used in the study.  Although it 
appears that there was a significant spread in the data gathered (self-reported self-esteem, Quality 
of Life, and Expected Weight Loss), these were also the 3 hypotheses that did not show 
significant results.  Subjects may sometimes over-report symptoms to make themselves more 
eligible for studies or even under-report to prevent disqualification from studies.  In measuring 
attrition, Fabricatore et al. (2011) attempted to follow up with reasons for attrition.  This attrition 
data were not explored because it was outside the scope of this study.  It is possible that many 
people did not drop out of the study for issues related to motivation or to being unhappy with 
their progress.  It is possible that some people may have left early if they had lost an acceptable 
amount of weight and were happy with their early results.  These subjects would have been 
captured in the measurement of success because of using the “last weight carried forward” 
approach in the study, but they still would have been counted as dropping out of the study before 
40 weeks. 
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Finally, the statistical analysis used in the study has its own set of problematic issues due 
to the relatively limited sample size. Nemes, Jonasson, Genell, and Steineck (2009) found that 
many times, the odds ratios calculated by logistic regression analysis tend to be inflated when 
using small sample sizes in studies.  Although there was a fairly even distribution when 
separating the data into tertiles in order to run the logistic regression analysis, there was still a 
limited amount of data to start with and therefore each tertile ended by being very small.  The 
fact that the sample was small reduced the confidence and accuracy in the estimates.   
Future Directions 
 
Future study should continue to target specific differences and challenges that diabetes 
may present for patients attempting to lose weight or to engage in other lifestyle modification 
programs.  Further exploration of cognitive and behavioral influences to attrition and success 
will be needed.  Cognitive factors such as understanding of the illness, internal thought 
processes, feelings of helplessness, and hopelessness for change may aid researchers in 
predicting attrition and success with this population.  Behavioral factors such as previous dieting 
attempts, dietary behaviors, medications, and number of support systems may also increase 
knowledge and aid researchers in designing programs that will be more successful in treating this 
population.  Because this research was done with a limited population size, recreating the current 
study with a focus on a larger and more diverse subject pool may result in more positive and 
significant findings.  Researchers should proceed to explore the many different factors leading to 
success and attrition in lifestyle modification programs designed for weight reduction because 
this problem continues to grow and affect the health and life quality of those suffering from 
obesity and from obesity-related illnesses such as diabetes.   
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